December 26, 2025
The simulators market size is forecast to increase from USD 14.72 billion in 2026 to USD 25.53 billion by 2034...
Read MoreDecember 26, 2025
The anti-aging market size is forecast to grow from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
According to market projections, the global allergy diagnostics market, valued at USD 5.79 billion in 2024, is anticipated to reach USD 16.45 billion by 2034, growing at a CAGR of 10.96% over the next decade. The rising incidence of allergies and technological advancements bolster market growth. North America dominated the global market due to the ...
November 01, 2025
Based on market forecasts, the global syphilis testing market, projected at USD 2.29 billion in 2024, is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% over the forecast period. The market is expanding due to the global increase in syphilis cases and other sexually transmitted infections. Growth is further fueled by rising a...
November 01, 2025
Projections indicate that, the global preimplantation genetics diagnosis (PGD) market will increase from USD 67.79 million in 2024 to USD 144.19 million by 2034, experiencing a CAGR of 7.84% over the next 10 years. The preimplantation genetics diagnosis (PGD) market is expanding due to growing advancements as well as increasing IVF usage. North Ame...
November 01, 2025
According to market projections, the immunoassay sector is expected to grow from USD 35.61 billion in 2024 to USD 56.54 billion by 2034, reflecting a CAGR of 4.72%. Ongoing technological advances are propelling the global market growth. North America dominated the market due to a rise in demand for precision diagnostics, treatment, and R&D inve...
November 01, 2025
Projections indicate that, the U.S. immunoassay market will increase from USD 8.99 billion in 2024 to USD 14.22 billion by 2034, experiencing a CAGR of 4.93% over the next 10 years. The expansion of immunoassays in the U.S. goes beyond traditional diagnostics into areas like therapeutic drug monitoring, personalized medicine, and biomarker discover...
November 01, 2025
Market insights predict, the diagnostic testing industry is expected to grow from USD 203.3 billion in 2024 to USD 274.53 billion by 2034, driven by a CAGR of 3.04%. The rising prevalence of chronic and infectious diseases is estimated to drive the growth of the market. North America led the global market owing to its advanced healthcare infrastruc...
November 01, 2025
Projections indicate that, the global pathology laboratories market will increase from USD 380.95 billion in 2024 to USD 834.44 billion by 2034, experiencing a CAGR of 8.2% over the next 10 years. The market is growing due to the rising demand for early disease diagnosis and advanced diagnostic testing. North America leads the market due to technol...
November 01, 2025
Projections indicate that, direct-to-consumer laboratory testing industry is projected to rise from USD 3.47 billion in 2024 to USD 8.16 billion by 2034, reflecting a CAGR of 8.94% over the next decade. The market is growing due to increasing consumer demand for convenient, at-home health insights and personalized care. Rising awareness of preventi...
November 01, 2025
Based on market forecasts, the non-invasive prenatal testing sector will expand from USD 6.45 billion in 2024 to USD 18.94 billion by 2034, experiencing a CAGR of 11.65%. The non-invasive prenatal testing market is growing due to the increasing demand for safer, earlier, and accurate detection of fetal genetic disorders. North America is dominating...
November 01, 2025
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of point-of-care testing for infectious diseases in the U.S. is driven by improved patient outcomes, inc...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com